[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fIwoUnoZQl8HQ03R0iM2hLTfXjoGBWH3TQ-GwGREnOgo":8,"$feans91XNEq7xQBQqy5NOH13W3E3g2wcAgECKMZvMHu8":55,"$fdbQEFtEUXJIP2rObbY7FCX6ANd3kH_ow8YVy5aOiO5Q":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65428,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"鼻咽恶性肿瘤放化疗药品实用用药指南","","https://ystcdn.venuertc.com/venue/AI/f8b08028-17c9-4002-b56a-9512cf55eaca.jpg","\u003Cdiv class=\"tumor-drugguide-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"tumor-drugguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">鼻咽恶性肿瘤放化疗药品实用用药指南\u003C/h2>\n  \n  \u003Csection class=\"tumor-drugguide-section tumor-drugguide-intro\">\n      \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n      \u003Cp>日常说到\"抗肿瘤药\"，很多人脑海里会浮现那些化疗药物名字。其实用于鼻咽部恶性肿瘤的放化疗，常常会用到几类药，比如顺铂、紫杉醇、多柔比星等，这些药在发挥作用时要求特别严格。本文将理清鼻咽恶性肿瘤治疗用药的7个关键细节：从药物作用到服用方法、药物之间的互动、常见不良反应、储存方式到特殊人群如何安全用药，帮你真正做到了解、用对、不慌张。\u003C/p>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 放化疗常用药简介与作用机制 💉\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>顺铂（Cisplatin）\u003C/strong>：属于铂类化疗药。通过与DNA结合，阻断其复制，从而抑制肿瘤细胞增殖。\u003Csup>[1]\u003C/sup>\u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇（Paclitaxel）\u003C/strong>：微管抑制剂类药物，使得肿瘤细胞分裂过程受阻。\u003Csup>[2]\u003C/sup>\u003C/li>\n      \u003Cli>\u003Cstrong>多柔比星（Doxorubicin）\u003C/strong>：蒽环类药物，通过干扰DNA/RNA合成杀伤肿瘤细胞。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥（S-1）\u003C/strong>：口服氟尿嘧啶类似物，阻断肿瘤细胞DNA合成，常与放疗协同。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗（Trastuzumab）\u003C/strong>：单克隆抗体药物，针对特定受体，阻断信号通路，有的方案中用作联合靶向治疗。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>补充说明：\u003C/span>化疗类、靶向类药物的抗肿瘤机理各不相同，需根据治疗方案选用，不能擅自更换。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 用药方法与剂型要点 🔬\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>顺铂、紫杉醇、多柔比星\u003C/strong>：多以静脉注射为主，给药需在医院专业环境下，由医护人员操作。家庭无法自行注射，不能改为口服。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥\u003C/strong>：为胶囊口服，须整粒吞服，不可嚼碎或碾碎；宜饭后服用以减少胃肠刺激。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗\u003C/strong>：须稀释静脉滴注，注射速度与剂量需严格把控，仅限医疗机构操作。\u003C/li>\n      \u003Cli>\u003Cstrong>补液配伍\u003C/strong>：如顺铂、紫杉醇通常需配合大量补液以减少肾脏负担和降低毒性。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>正确做法：\u003C/span>用药期间如有疑问，务必按医师方案执行，不擅自更改剂量或用法。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 用量与间隔——用药切勿随意 ⏰\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>顺铂\u003C/strong>：常用剂量60-100 mg/m²，每21天一个疗程，具体剂量须依据患者体表面积和肾功能调整。\u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>：常用剂量135-175 mg/m²，静滴时间通常为3小时；用药间隔由医嘱决定。\u003C/li>\n      \u003Cli>\u003Cstrong>多柔比星\u003C/strong>：60-75 mg/m²，静注，严防累计总剂量超限以避免心脏毒性。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥\u003C/strong>：每日2次，连续服用28天，休息14天为一周期。\u003C/li>\n      \u003Cli>\u003Cstrong>叠加用药\u003C/strong>：不少方案将上述药物两种或多种联合使用，严格需分开管路、顺序、速率。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>实际案例：\u003C/span>临床上有患者擅自缩短顺铂用药间隔，导致副作用骤增。因此无论疗程感受如何，不得私自改动用药计划。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用须小心 💡\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>与同类抗肿瘤药联用\u003C/strong>：如顺铂与紫杉醇同用时，若顺序颠倒，可能影响药效并加剧毒性。通常建议紫杉醇先用。\u003C/li>\n      \u003Cli>\u003Cstrong>与止吐药/抗生素/常规药物互动\u003C/strong>：顺铂多与地塞米松、昂丹司琼等止吐药联合，用法须分别稀释。\u003C/li>\n      \u003Cli>\u003Cstrong>与补钾/补镁类药物\u003C/strong>：顺铂易造成电解质失衡，补充钾镁时需与主药分开静滴。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥与华法林等抗凝药\u003C/strong>：可能相互增强，增加出血风险，须定期监测凝血。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>需要注意：\u003C/span>服用任何新药，包括中成药、保健品，应提前向医生说明，防止潜在药物相互作用。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应与处理办法 ⚠️\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>顺铂\u003C/strong>：常见呕吐、肾毒性和耳毒性。说明书提示肾损伤风险较高，必须充分补液，出现尿量减少需及时告知医务人员。\u003C/li>\n      \u003Cli>\u003Cstrong>紫杉醇\u003C/strong>：可能引起过敏反应、脱发、外周神经病变。用药前建议预处理抗过敏药物。\u003C/li>\n      \u003Cli>\u003Cstrong>多柔比星\u003C/strong>：有心脏毒性，累计剂量超标风险骤升。定期评估心脏功能，任何心悸胸闷都需及时报告。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥\u003C/strong>：口腔溃疡、腹泻较为常见。严重腹泻时须停药并联系医生。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗\u003C/strong>：心脏功能受损、过敏性反应可能发生，用药期间严密监测。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>正确做法：\u003C/span>化疗期如发现异常反应，不轻视、不拖延，务必通知医护人员处理，切勿私自增减药物。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 储存与保存——药品如何不变质 🗃️\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>顺铂、紫杉醇、多柔比星等注射液\u003C/strong>：医院药房配制后及时使用，未开封原液按药品说明要求冷藏（通常为2-8℃）。\u003C/li>\n      \u003Cli>\u003Cstrong>替吉奥（S-1）胶囊\u003C/strong>：室温干燥、避光处密封保存。防止儿童误服或受潮。\u003C/li>\n      \u003Cli>\u003Cstrong>曲妥珠单抗\u003C/strong>：原液冷藏保存，调配后24小时内使用完毕，超过请勿再用。\u003C/li>\n      \u003Cli>\u003Cstrong>过期药物\u003C/strong>：失效药品必须封存丢弃，不得擅自服用或继续使用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>特别提醒：\u003C/span>家庭保存化疗药品极为罕见需严格。普通患者仅需关注口服药（如替吉奥）存放，其他药品仅在医院管理。\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 特殊人群用药细则 👨‍👩‍👧‍👦\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>肾功能不全患者\u003C/strong>：顺铂、替吉奥等需调整剂量或停用，具体由医生评估决定。\u003C/li>\n      \u003Cli>\u003Cstrong>老年患者\u003C/strong>：紫杉醇、多柔比星等药品需考虑肝肾功能、心功能，剂量不宜过大。定期评估身体状况，减少不良反应风险。\u003C/li>\n      \u003Cli>\u003Cstrong>孕妇及哺乳期妇女\u003C/strong>：多种抗肿瘤药物禁止使用于怀孕或哺乳期间，以防对胎儿或婴儿造成伤害。\u003C/li>\n      \u003Cli>\u003Cstrong>儿童及青少年\u003C/strong>：化疗方案须严格按体重、体表面积、发展阶段设定；用药更需注意药物毒性。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"tumor-drugguide-tips\">\n        \u003Cspan>正确做法：\u003C/span>任何特殊情况均应向专业医生如实告知个人身体状况，配合医生完成用药调整。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏用与过量处理 ➕\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-bullet\">\n      \u003Cli>\u003Cstrong>漏服口服药\u003C/strong>：如替吉奥忘记服用，想起来时若临近下次服药时间，则跳过本次，不多服。切勿自行补药或增量。\u003C/li>\n      \u003Cli>\u003Cstrong>注射类药物\u003C/strong>：如因特殊原因未按疗程注射，应立即联系医生安排补充方案，绝不可自己寻找注射途径。\u003C/li>\n      \u003Cli>\u003Cstrong>过量问题\u003C/strong>：无论哪一类药物，一旦不慎过量，须立即报告医务人员。部分药品有解毒药（如地塞米松降低反应），但需医院操作。\u003C/li>\n      \u003Cli>\u003Cstrong>自我处理\u003C/strong>：出现明显异常，不可擅自停药或自行补救，一切按照医生及护理人员指导执行。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 用药真实案例一览 🌟\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-case\">\n      \u003Cli>一位女性患者在肿瘤放化疗过程中，规范静脉注射顺铂和口服替吉奥，未发生明显不良反应，顺利完成疗程。\u003C/li>\n      \u003Cli>有患者因漏服替吉奥，未自行补服，及时与医生沟通并完成后续调整，无明显副作用。\u003C/li>\n      \u003Cli>临床中有患者因随意调整顺铂剂量，短期内肾功能恶化，提醒严格依照医嘱执行给药计划。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n  \n  \u003Csection class=\"tumor-drugguide-section\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch2 class=\"tumor-drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 必知用药小结与安全提示 📝\u003C/h2>\n    \u003Cul class=\"tumor-drugguide-mainpoints\">\n      \u003Cli>放化疗药物对身体作用强，务必听从医生安排，不随意更改剂量及方案。\u003C/li>\n      \u003Cli>遇到不良反应，不忽视也不慌张，及时告诉专业人员，切勿自行处理。\u003C/li>\n      \u003Cli>合理保存口服药，远离儿童，注射药品全部医院把控。\u003C/li>\n      \u003Cli>任何情况下，不擅自加药或减药，真正做到安全、规范、高质量地完成每一轮疗程。\u003C/li>\n      \u003Cli>遇到疑问或异常，首选咨询专科医师。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n  \n  \u003Cfooter class=\"tumor-drugguide-footer\">\n    \u003Cdiv class=\"tumor-drugguide-section-bg\">\u003C/div>\n    \u003Ch3 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要参考文献 📚\u003C/h3>\n    \u003Col>\n      \u003Cli>Van der Vijgh, W.J.F. (2001). Clinical pharmacokinetics of cisplatin and its analogues. Clinical Pharmacokinetics, 16(5), 295–307.\u003C/li>\n      \u003Cli>Markman, M., & Markman, M. (2003). Safety profile of the taxanes. Journal of Clinical Oncology, 21(Suppl 10), 28s-34s.\u003C/li>\n      \u003Cli>UpToDate. (2024). Systemic therapy for head and neck cancer, including nasopharyngeal. Wolters Kluwer, accessed June 2024.\u003C/li>\n      \u003Cli>National Comprehensive Cancer Network (NCCN). (2023). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers.\u003C/li>\n      \u003Cli>Mayo Clinic. (2023). Drugs and Medications for Nasopharyngeal Cancer. MayoClinic.org.\u003C/li>\n    \u003C/ol>\n    \u003Cdiv class=\"tumor-drugguide-remark\">\n      \u003Cem>以上内容仅作科普参考。关于药物使用，详细依照医生处方及医疗机构实际管理为准。\u003C/em>\n    \u003C/div>\n  \u003C/footer>\n\u003C/div>\n\n\u003Cstyle>\n.tumor-drugguide-wrap {\n  max-width: 780px;\n  padding: 32px 22px 48px 22px;\n  margin: 40px auto;\n  background: #f7fafc;\n  border-radius: 18px;\n  box-shadow: 0 2px 16px rgba(60,85,133,0.08);\n  font-family: 'Helvetica Neue', Helvetica, Arial, \"PingFang SC\", sans-serif;\n  color: #293144;\n  box-sizing: border-box;\n}\n.tumor-drugguide-title {\n  font-size: 2.1rem;\n  font-weight: 700;\n  color: #27345a;\n  letter-spacing: 1px;\n  margin-bottom: 32px;\n  text-align: center;\n  background: linear-gradient(90deg, #ecf1fe 40%, #f9f9f9 100%);\n  padding: 25px 0 15px 0;\n  border-radius: 15px 15px 0 0;\n}\n.tumor-drugguide-section {\n  position: relative;\n  margin-bottom: 38px;\n  padding: 36px 18px 22px 18px;\n  border-radius: 12px;\n  overflow: hidden;\n  background: none;\n}\n.tumor-drugguide-section-bg {\n  background: url(\"data:image/svg+xml,%3Csvg width='1440' height='160' viewBox='0 0 1440 160' fill='none' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath fill-rule='evenodd' clip-rule='evenodd' d='M0 81.6224C196.968 -25.0185 372.624 87.3685 720 110.622C1067.38 133.876 1290.77 29.0103 1440 48.6224V160H0V81.6224Z' fill='%23eef3fb'/%3E%3C/svg%3E\") repeat-x left bottom;\n  background-size: auto 120px;\n  background-position: left bottom;\n  opacity: 0.32;\n  width: 100%;\n  height: 120px;\n  left: 0;\n  bottom: 0;\n  position: absolute;\n  z-index: 0;\n  pointer-events: none;\n  border-radius: 12px;\n}\n.tumor-drugguide-subtitle {\n  position: relative;\n  font-size: 1.27rem;\n  font-weight: 600;\n  color: #235497;\n  margin-bottom: 20px;\n  padding-bottom: 7px;\n  z-index: 2;\n  letter-spacing: 0.5px;\n}\n.tumor-drugguide-bullet, .tumor-drugguide-mainpoints, .tumor-drugguide-case {\n  margin: 16px 0 14px 0;\n  padding-left: 28px;\n  z-index: 2;\n  position: relative;\n}\n.tumor-drugguide-bullet li,\n.tumor-drugguide-mainpoints li,\n.tumor-drugguide-case li {\n  margin-bottom: 10px;\n  font-size: 1.04rem;\n  line-height: 1.8;\n  color: #253150;\n  position: relative;\n}\n.tumor-drugguide-bullet li:before {\n  content: \"•\";\n  color: #42addb;\n  margin-right: 8px;\n  font-weight: bold;\n  font-size: 1.02em;\n}\n.tumor-drugguide-mainpoints li:before {\n  content: \"✔ \";\n  color: #48948a;\n  font-size: 1.11em;\n  margin-right: 5px;\n}\n.tumor-drugguide-case li:before {\n  content: \"✓ \";\n  color: #d39953;\n  font-size: 1.12em;\n  margin-right: 7px;\n}\n.tumor-drugguide-tips {\n  background: #e6f3fa;\n  color: #234073;\n  padding: 12px 18px;\n  border-radius: 6px;\n  margin-top: 16px;\n  font-size: 1.01rem;\n  border-left: 5px solid #9ec2eb;\n  z-index: 2;\n  position: relative;\n}\n.tumor-drugguide-tips span {\n  color: #166194;\n  font-weight: 600;\n  margin-right: 7px;\n}\n.tumor-drugguide-footer {\n  background: #f5faff;\n  padding: 32px 18px 18px 18px;\n  border-radius: 0 0 15px 15px;\n  text-align: left;\n  margin-top: 26px;\n  z-index: 2;\n  position: relative;\n}\n.tumor-drugguide-footer h3 {\n  color: #3967a7;\n  font-size: 1.13rem;\n  font-weight: 700;\n  margin-bottom: 12px;\n}\n.tumor-drugguide-footer ol {\n  margin: 0 0 10px 20px;\n  padding-left: 0;\n}\n.tumor-drugguide-footer li {\n  font-size: 0.98rem;\n  color: #38516c;\n  line-height: 1.7;\n  margin-bottom: 6px;\n}\n.tumor-drugguide-remark {\n  color: #7b7f91;\n  margin-top: 10px;\n  font-size: 0.98rem;\n  font-style: italic;\n}\n@media (max-width: 600px) {\n  .tumor-drugguide-wrap {padding: 14px 2px;}\n  .tumor-drugguide-title, .tumor-drugguide-footer {padding-right: 2px; padding-left:2px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"tumor-drugguide-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"tumor-drugguide-title\" style=\"co",572,"2025-09-02 09:27:13","鼻咽恶性肿瘤, 放化疗药物, 顺铂, 紫杉醇, 用药指南, 化疗不良反应, 特殊人群用药, 医疗安全","了解鼻咽恶性肿瘤的放化疗药品，包括顺铂、紫杉醇等的作用机制、用药方法、不良反应及特殊人群用药细则，提高治疗效果，确保安全使用。","2025-09-03 07:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]